Shawn Cao

Visible and Subvisible Protein Particle Inspection Within a QbD-Based Strategy

Shawn Cao, Erwin Freund, S. Cao, 2015 .

Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab

Shawn Cao, Jennifer Liu, Tamer Eris, 2016, BioDrugs.

Separation and characterization of protein aggregates and particles by field flow fractionation.

Joey Pollastrini, Yijia Jiang, Shawn Cao, 2009, Current pharmaceutical biotechnology.